Of the Class III family members Sirtuins (Sirts1-7), Sirt1 has been shown to have altered expression in lung cancer, with 46.4% (45/97) of tumors showing an absence or low expression of SIRT1 protein (Table 2), which was linked to poor prognosis [76]. This evidence concerns the gene SIRT1 and lung carcinoma.